Huntington disease reduced penetrance alleles occur at high frequency in the general population

Chris Kay, Jennifer A. Collins, Zosia Miedzybrodzka, Steven J. Madore, Erynn S. Gordon, Norman Gerry, Mark Davidson, Ramy A. Slama, Michael R Hayden

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: To directly estimate the frequency and penetrance of CAG repeat alleles associated with Huntington disease (HD) in the general population.

Methods: CAG repeat length was evaluated in 7,315 individuals from 3 population-based cohorts from British Columbia, the United States, and Scotland. The frequency of ≥36 CAG alleles was assessed out of a total of 14,630 alleles. The general population frequency of reduced penetrance alleles (36–39 CAG) was compared to the prevalence of patients with HD with genetically confirmed 36–39 CAG from a multisource clinical ascertainment in British Columbia, Canada. The penetrance of 36–38 CAG repeat alleles for HD was estimated for individuals ≥65 years of age and compared against previously reported clinical penetrance estimates.

Results: A total of 18 of 7,315 individuals had ≥36 CAG, revealing that approximately 1 in 400 individuals from the general population have an expanded CAG repeat associated with HD (0.246%). Individuals with CAG 36–37 genotypes are the most common (36, 0.096%; 37, 0.082%; 38, 0.027%; 39, 0.000%; ≥40, 0.041%). General population CAG 36–38 penetrance rates are lower than penetrance rates extrapolated from clinical cohorts.
Original languageEnglish
Pages (from-to)282-288
Number of pages7
JournalNeurology
Volume87
Issue number3
Early online date22 Jun 2016
DOIs
Publication statusPublished - Jul 2016

Fingerprint

Penetrance
Huntington Disease
Alleles
Population
British Columbia
Scotland
Canada
Genotype

Cite this

Kay, C., Collins, J. A., Miedzybrodzka, Z., Madore, S. J., Gordon, E. S., Gerry, N., ... Hayden, M. R. (2016). Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology, 87(3), 282-288. https://doi.org/10.1212/WNL.0000000000002858

Huntington disease reduced penetrance alleles occur at high frequency in the general population. / Kay, Chris; Collins, Jennifer A.; Miedzybrodzka, Zosia; Madore, Steven J.; Gordon, Erynn S.; Gerry, Norman; Davidson, Mark; Slama, Ramy A.; Hayden, Michael R.

In: Neurology, Vol. 87, No. 3, 07.2016, p. 282-288.

Research output: Contribution to journalArticle

Kay, C, Collins, JA, Miedzybrodzka, Z, Madore, SJ, Gordon, ES, Gerry, N, Davidson, M, Slama, RA & Hayden, MR 2016, 'Huntington disease reduced penetrance alleles occur at high frequency in the general population', Neurology, vol. 87, no. 3, pp. 282-288. https://doi.org/10.1212/WNL.0000000000002858
Kay, Chris ; Collins, Jennifer A. ; Miedzybrodzka, Zosia ; Madore, Steven J. ; Gordon, Erynn S. ; Gerry, Norman ; Davidson, Mark ; Slama, Ramy A. ; Hayden, Michael R. / Huntington disease reduced penetrance alleles occur at high frequency in the general population. In: Neurology. 2016 ; Vol. 87, No. 3. pp. 282-288.
@article{1af421f349204a90b5860e1a62666e81,
title = "Huntington disease reduced penetrance alleles occur at high frequency in the general population",
abstract = "Objective: To directly estimate the frequency and penetrance of CAG repeat alleles associated with Huntington disease (HD) in the general population.Methods: CAG repeat length was evaluated in 7,315 individuals from 3 population-based cohorts from British Columbia, the United States, and Scotland. The frequency of ≥36 CAG alleles was assessed out of a total of 14,630 alleles. The general population frequency of reduced penetrance alleles (36–39 CAG) was compared to the prevalence of patients with HD with genetically confirmed 36–39 CAG from a multisource clinical ascertainment in British Columbia, Canada. The penetrance of 36–38 CAG repeat alleles for HD was estimated for individuals ≥65 years of age and compared against previously reported clinical penetrance estimates.Results: A total of 18 of 7,315 individuals had ≥36 CAG, revealing that approximately 1 in 400 individuals from the general population have an expanded CAG repeat associated with HD (0.246{\%}). Individuals with CAG 36–37 genotypes are the most common (36, 0.096{\%}; 37, 0.082{\%}; 38, 0.027{\%}; 39, 0.000{\%}; ≥40, 0.041{\%}). General population CAG 36–38 penetrance rates are lower than penetrance rates extrapolated from clinical cohorts.",
author = "Chris Kay and Collins, {Jennifer A.} and Zosia Miedzybrodzka and Madore, {Steven J.} and Gordon, {Erynn S.} and Norman Gerry and Mark Davidson and Slama, {Ramy A.} and Hayden, {Michael R}",
year = "2016",
month = "7",
doi = "10.1212/WNL.0000000000002858",
language = "English",
volume = "87",
pages = "282--288",
journal = "Neurology",
issn = "0028-3878",
publisher = "AAN Enterprises",
number = "3",

}

TY - JOUR

T1 - Huntington disease reduced penetrance alleles occur at high frequency in the general population

AU - Kay, Chris

AU - Collins, Jennifer A.

AU - Miedzybrodzka, Zosia

AU - Madore, Steven J.

AU - Gordon, Erynn S.

AU - Gerry, Norman

AU - Davidson, Mark

AU - Slama, Ramy A.

AU - Hayden, Michael R

PY - 2016/7

Y1 - 2016/7

N2 - Objective: To directly estimate the frequency and penetrance of CAG repeat alleles associated with Huntington disease (HD) in the general population.Methods: CAG repeat length was evaluated in 7,315 individuals from 3 population-based cohorts from British Columbia, the United States, and Scotland. The frequency of ≥36 CAG alleles was assessed out of a total of 14,630 alleles. The general population frequency of reduced penetrance alleles (36–39 CAG) was compared to the prevalence of patients with HD with genetically confirmed 36–39 CAG from a multisource clinical ascertainment in British Columbia, Canada. The penetrance of 36–38 CAG repeat alleles for HD was estimated for individuals ≥65 years of age and compared against previously reported clinical penetrance estimates.Results: A total of 18 of 7,315 individuals had ≥36 CAG, revealing that approximately 1 in 400 individuals from the general population have an expanded CAG repeat associated with HD (0.246%). Individuals with CAG 36–37 genotypes are the most common (36, 0.096%; 37, 0.082%; 38, 0.027%; 39, 0.000%; ≥40, 0.041%). General population CAG 36–38 penetrance rates are lower than penetrance rates extrapolated from clinical cohorts.

AB - Objective: To directly estimate the frequency and penetrance of CAG repeat alleles associated with Huntington disease (HD) in the general population.Methods: CAG repeat length was evaluated in 7,315 individuals from 3 population-based cohorts from British Columbia, the United States, and Scotland. The frequency of ≥36 CAG alleles was assessed out of a total of 14,630 alleles. The general population frequency of reduced penetrance alleles (36–39 CAG) was compared to the prevalence of patients with HD with genetically confirmed 36–39 CAG from a multisource clinical ascertainment in British Columbia, Canada. The penetrance of 36–38 CAG repeat alleles for HD was estimated for individuals ≥65 years of age and compared against previously reported clinical penetrance estimates.Results: A total of 18 of 7,315 individuals had ≥36 CAG, revealing that approximately 1 in 400 individuals from the general population have an expanded CAG repeat associated with HD (0.246%). Individuals with CAG 36–37 genotypes are the most common (36, 0.096%; 37, 0.082%; 38, 0.027%; 39, 0.000%; ≥40, 0.041%). General population CAG 36–38 penetrance rates are lower than penetrance rates extrapolated from clinical cohorts.

U2 - 10.1212/WNL.0000000000002858

DO - 10.1212/WNL.0000000000002858

M3 - Article

VL - 87

SP - 282

EP - 288

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -